Nanobiotix S.A.
NBTX | NASDAQ
$34.63
+$0.13 (+0.38%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.01M | 26.64M | -20.9M | 9.29M | 32.92M | 3.29M | 1.72M | 664.5K | 664K | 10K | 13K | 37K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 754K | 746K | 759K | -649.5K | -425.5K | -687K |
Gross Profit | 3.01M | 26.64M | -20.9M | 9.29M | 32.92M | 3.29M | 969.5K | -81.5K | -95K | 659.5K | 438.5K | 724K |
Operating Income | -11.63M | 808K | -44.74M | -23.65M | -1.41M | -25.37M | -24.25M | -26.25M | -24.13M | -25.67M | -19.1M | -19.91M |
Interest Income | 985K | n/a | 2.63M | n/a | n/a | n/a | 250K | 1.36M | 1.22M | 1.56M | 1.03M | n/a |
Pretax Income | -18.58M | -5.38M | -46.3M | -21.73M | -11.48M | -28.1M | -33.72M | -27.4M | -17.84M | -31.65M | -14.04M | -21.47M |
Net Income | -18.58M | -5.38M | -46.26M | -21.87M | -11.6M | -28.1M | -30.68M | -26.36M | -16.58M | -30.42M | -13.01M | -20.58M |
Selling & General & Admin | 8.93M | 11.29M | 9.69M | 10.83M | 11.19M | 10.86M | 7.98M | 9.5M | 9.02M | 10M | 7.73M | 6.49M |
Research & Development | 8.59M | 14.53M | 18.55M | 21.99M | 20.59M | 17.81M | 15.53M | 15.94M | 14.35M | 14.88M | 10.55M | 12.49M |
Other Expenses | -2.88M | 7K | -4.41M | 121K | 2.55M | -6K | -25K | 68K | n/a | n/a | -12K | 52K |
Operating Expenses | 14.63M | 25.83M | 23.84M | 32.94M | 34.32M | 28.66M | 23.49M | 25.5M | 23.37M | 24.88M | 18.26M | 19.04M |
Interest Expense | 6.75M | 3.65M | 8.09M | n/a | 3.4M | 3.37M | 3.11M | n/a | n/a | n/a | n/a | 1.19M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.5K |
Cost & Expenses | 14.63M | 25.83M | 23.84M | 32.94M | 34.32M | 28.66M | 24.25M | 26.25M | 24.13M | 25.68M | 19.11M | 19.94M |
Income Tax Expense | -3K | 6K | -43K | 144K | 117K | 3K | -3.03M | -1.05M | -1.26M | -1.23M | -1.03M | -887K |
Shares Outstanding (Basic) | 47.82M | 47.42M | 47.27M | 47.12M | 37.99M | 35.04M | 34.85M | 34.84M | 34.81M | 34.62M | 27.85M | 22.61M |
Shares Outstanding (Diluted) | 47.82M | 47.42M | 47.27M | 47.12M | 38.82M | 35.04M | 34.85M | 34.84M | 34.81M | 34.62M | 27.85M | 22.61M |
EPS (Basic) | -0.39 | -0.11 | -0.98 | -0.46 | -0.30 | -0.80 | -0.88 | -0.76 | -0.48 | -0.88 | -0.47 | -0.91 |
EPS (Diluted) | -0.39 | -0.11 | -0.98 | -0.46 | -0.31 | -0.80 | -0.88 | -0.76 | -0.48 | -0.88 | -0.47 | -0.91 |
EBITDA | -13.16M | 1.09M | -35.08M | -23.24M | 1.41M | -24.64M | -10.26M | -11.71M | -10.55M | -11.38M | -8.14M | -8.74M |
EBIT | -14.38M | 815K | -36.41M | -23.53M | 1.14M | -25.38M | -10.4M | -12.46M | -11.4M | -12.18M | -9.12M | -9.19M |
Depreciation & Amortization | 1.22M | 276K | 1.33M | 287K | 274K | 741K | 754K | 746K | 759K | 801K | 849K | 906K |
Add to Watchlist
Select watchlists to add or remove NBTX